Benjamin Landry Health Catalyst, Inc. (HCAT) insider trading activity

Benjamin Landry is General Counsel of Health Catalyst, Inc.. Currently has a direct ownership of 160,437 shares of HCAT, which is worth approximately $726,779. The most recent transaction as insider was on Mar 06, 2025, when has been sold 13,827 shares (Common Stock) at a price of $4.55 per share, resulting in proceeds of $62,912. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 160K

122.06% 3M change

32.71% 12M change

Total Value Held $726,779

Benjamin Landry Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2025	SELL Open market or private sale	$62,912 $4.55 p/Share	13,827 Reduced 7.93%	160,437 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$41,329 $4.58 p/Share	9,024 Reduced 4.92%	174,264 Common Stock
Feb 20 2025	BUY Grant, award, or other acquisition	-	111,038 Added 37.73%	183,288 Common Stock
Jan 06 2025	SELL Open market or private sale	$18,800 $7.52 p/Share	2,500 Reduced 3.34%	72,250 Common Stock
Dec 06 2024	SELL Open market or private sale	$160,309 $8.32 p/Share	19,268 Reduced 21.05%	72,250 Common Stock
Dec 01 2024	SELL Payment of exercise price or tax liability	$84,488 $8.97 p/Share	9,419 Reduced 9.33%	91,518 Common Stock
Sep 06 2024	SELL Open market or private sale	$18,223 $7.39 p/Share	2,466 Reduced 2.38%	100,937 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$8,883 $7.27 p/Share	1,222 Reduced 1.17%	103,403 Common Stock
Jun 06 2024	SELL Open market or private sale	$16,016 $6.71 p/Share	2,387 Reduced 2.23%	104,625 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$8,489 $6.53 p/Share	1,300 Reduced 1.2%	107,012 Common Stock
May 31 2024	SELL Open market or private sale	$83,133 $6.61 p/Share	12,577 Reduced 10.4%	108,312 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$26,685 $8.05 p/Share	3,315 Reduced 2.67%	120,889 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	79,444 Added 39.01%	124,204 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$25,531 $7.45 p/Share	3,427 Reduced 7.11%	44,760 Common Stock
Oct 05 2023	BUY Grant, award, or other acquisition	-	20,000 Added 29.33%	48,187 Common Stock
Sep 06 2023	SELL Open market or private sale	$13,328 $11.52 p/Share	1,157 Reduced 3.94%	28,187 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$5,890 $11.78 p/Share	500 Reduced 1.68%	29,344 Common Stock
Jul 07 2023	SELL Open market or private sale	$13,134 $11.14 p/Share	1,179 Reduced 3.8%	29,844 Common Stock
Jun 06 2023	SELL Open market or private sale	$12,763 $11.84 p/Share	1,078 Reduced 3.49%	29,844 Common Stock
Jun 01 2023	SELL Payment of exercise price or tax liability	$6,485 $11.24 p/Share	577 Reduced 1.83%	30,922 Common Stock
May 03 2023	BUY Grant, award, or other acquisition	-	20,000 Added 38.84%	31,499 Common Stock

Benjamin Landry

General Counsel

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account